![John C. Davis](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John C. Davis
Direktor/Vorstandsmitglied bei
Rheos Medicines, Inc.
Profil
John C.
Davis is currently a Director at Rheos Medicines, Inc., a Director at Sonoma Biotherapeutics, Inc., and a Non-Executive Director at Nucleome Therapeutics Ltd. Previously, he held positions as a Senior Group Director at Genentech, Inc. from 2007 to 2015, Senior VP & Head-Early Clinical Development at Pfizer Inc. from 2016 to 2018, Vice President & Head-Global Therapeutic Area at Baxalta, Inc. in 2015, and Chief Medical Officer, Head-Research & Development at Magenta Therapeutics, Inc. from 2020 to 2021.
He also served as a Professor at The University of California, San Francisco.
Dr. Davis obtained a graduate degree from the University of California, Berkeley and the University of Maryland School of Medicine.
Aktive Positionen von John C. Davis
| Unternehmen | Position | Beginn |
|---|---|---|
Rheos Medicines, Inc.
 Rheos Medicines, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company developing novel medicines that modulate metabolic pathways in immune cells to treat disease | Direktor/Vorstandsmitglied | 13.07.2021 |
Sonoma Biotherapeutics, Inc.
 Sonoma Biotherapeutics, Inc. BiotechnologyHealth Technology Engages in research, development and manufacturing cell and genetic therapy for autoimmune and degenerative diseases | Direktor/Vorstandsmitglied | 17.08.2022 |
Nucleome Therapeutics Ltd.
 Nucleome Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops small molecular drugs for autoimmune diseases | Direktor/Vorstandsmitglied | 25.04.2024 |
Ehemalige bekannte Positionen von John C. Davis
| Unternehmen | Position | Ende |
|---|---|---|
| MAGENTA THERAPEUTICS | Technik-/Wissenschafts-/F&E-Leiter | 30.07.2021 |
| PFIZER INC. | Corporate Officer/Principal | 01.01.2018 |
| BAXALTA INC | Corporate Officer/Principal | 01.01.2016 |
The University of California, San Francisco
 The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01.01.2015 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | 01.01.2015 |
Ausbildung von John C. Davis
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
76
Beziehungen ersten Grades
10
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 10 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Baxalta, Inc.
 Baxalta, Inc. Pharmaceuticals: MajorHealth Technology Engages in research, development and manufacture of therapies and biopharmaceutical products | Health Technology |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of California, San Francisco
The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Maryland School of Medicine
 University of Maryland School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Magenta Therapeutics, Inc.
 Magenta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures novel medicines | Health Technology |
Rheos Medicines, Inc.
Rheos Medicines, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company developing novel medicines that modulate metabolic pathways in immune cells to treat disease | Health Technology |
Sonoma Biotherapeutics, Inc.
Sonoma Biotherapeutics, Inc. BiotechnologyHealth Technology Engages in research, development and manufacturing cell and genetic therapy for autoimmune and degenerative diseases | Health Technology |
Nucleome Therapeutics Ltd.
Nucleome Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops small molecular drugs for autoimmune diseases | Health Technology |
